Bonjour, new guests from small-town India
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
25mwauro.eps
Though the Aurobindo Pharma stock has nosedived 17 per cent on the US FDA's ‘import alert' on the company's unit-VI manufacturing facility, the direct financial impact of this development is not all that significant in the near term.
Located in Hyderabad, this facility is used to manufacture Cephalosporin oral and injectable products.
While the exact reasons for the ban are not public yet, the management is trying to get more clarity on the issue from the drug authority. But until the alert is lifted, the company cannot make any shipment from its unit-VI to the US market. The facility was inspected by the US FDA in December 2010.
The facility contributed 3-4 per cent to its top line and is estimated to have generated about $35 million in US sales. The import alert, therefore, would mean an immediate opportunity loss of about $35 million.
However, loss of incremental sales from the facility could be higher, as the company may now have to revisit supply contracts with other customers too. Besides, it may have to take remediation measures, incur legal costs and also write-off excess inventory.
Notably, the facility was also being used for supplying to Pfizer, with whom Aurobindo Pharma has a long-term supply contract.
Clarity on FDA observations and the scope of the import ban would help shed more light on earnings implications of the event.
Interestingly, this isn't the first instance of an Indian pharma company getting a Form 483 from the US FDA. In the past, Cipla and Lupin too had got Form 483 and warning letters, but had managed to resolve the issue.
Puneet Dhawan of Accor is brimming with ideas on ways to revive the hospitality sector
Citroen’s first vehicle sports a novel design and European interiors. It is also meant to be as comfortable as ...
The pandemic is only the tip of the iceberg that the country’s cash-poor airlines — both regional and national ...
The government is yet to specify the framework of its recently announced old vehicle scrappage policy
With initial public offerings galore, we give you a cheat sheet to score some good grades
Biggest risk in selling funds in a rising scenario is exiting early and missing out on further gains
Go for a standard vector-borne diseases policy if you don’t have a regular health plan
No credit risk is an attraction, but note the nuances
After facing severe droughts for several years, farmers in western Maharashtra have turned the corner through ...
A toast to a traditional drip irrigation system still going strong in the Northeast
Raza Mir’s ‘Murder at the Mushaira’ works well as a historical novel that captures the sunset years of the ...
If you see garbage lying on the streets, remove it, says a dedicated plogger on a clean-up drive
Its name is the starting point of a brand’s journey and can make a big difference in the success sweepstakes
Sober spirits are the in thing
A peek into where ad spends went last year and where they are headed tomorrow
Can Swiggy Instamart disrupt the ecommerce groceries space, currently ruled by the Amazons and Big Baskets? ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor